Elevated serum uric acid independently increases risk of cardiometabolic disease and multimorbidity beyond gout alone, following a dose-dependent relationship. This metabolic marker represents a tractable intervention point for preventing disease clustering in midlife and later.
Key Points
- High uric acid predicts cardiometabolic disease independent of gout diagnosis
- Dose-dependent relationship between uric acid levels and multimorbidity risk
- Uric acid elevation precedes and accelerates transition to multiple chronic conditions
Longevity Analysis
Serum uric acid functions as an early warning signal that precedes the cascade into multiple concurrent chronic diseases. Rather than treating gout as an isolated condition, this evidence positions uric acid management as a metabolic intervention point that can interrupt the progression toward disease clustering—a primary driver of reduced healthspan. The dose-dependent relationship indicates that even subclinical elevation merits attention, suggesting that decoding this signal earlier and addressing its underlying causes offers leverage for preventing the functional decline associated with managing multiple conditions simultaneously.
Original published by Nature - npj Aging, by Chuanghai Wu.